Use of ingredients in infant formula for special medical purposes
Taiwan
Sep 30, 2022
The Taiwan Food and Drug Administration (TFDA) consulted on the amendment to the use restriction of 2′-fucosyllactose (2′-FL) produced by genetically modified Escherichia coli strain K-12 DH1 MDO MAP1001d (hereinafter referred to as “E. coli K-12 MAP1001d”) and genetically modified Escherichia coli strain BL21 (DE3) #1540 (hereinafter referred to as “E. coli BL21 (DE3) #1540”).
For further information (in Chinese), click on the Link
OSARTEC extends deadline for comments on new rules for nutrition labeling of children's food
El Salvador
Mar 18, 2024
FSSAI revises Standards for Children's Nutritional Foods
India
Mar 14, 2024
SAMR to require registration of liquid infant formula
China
Jan 24, 2024
Draft amendment to the regulation of foods for special diets and infant foods
Canada
Nov 30, 2023
Guidelines for Online Sales of Special Foods published
China
Oct 23, 2023
New Draft Technical Regulation on cereal-based foods for infants and young children
Paraguay
Jul 07, 2023
Partial Amendment on the Food Labeling Standards
Japan
Jul 03, 2023
2ʹ-fucosyllactose (2ʹ-fucosyllactose): restrictions of use and labeling requirements published by MHW
Taiwan
Jun 08, 2023
Enzymes approved as processing aids
Australia
Feb 20, 2023
Regulation of Baby Food Marketing in Thailand: A NetCode analysis
Thailand
Jul 06, 2022
Standard on complementary foods and nutritional supplements
China
Feb 28, 2022
Commission Implementing Decision on Decree on toddler drinks and toddler milk
Netherlands
Feb 07, 2022
Additional requirements on the use of claims on infant formula labeling
China
Nov 23, 2021
Amendments on Oat products and formulated supplements for children published by FSSAI
India
Nov 21, 2021
Decree on the advertising of food and beverages for children published by AESAN
Spain
Nov 12, 2021
